WIRC+Pol: A Low-resolution Near-infrared Spectropolarimeter

WIRC+Pol is a newly commissioned low-resolution (R ~ 100), near-infrared (J and H bands) spectropolarimetry mode of the Wide-field InfraRed Camera (WIRC) on the 200 inch Hale Telescope at Palomar Observatory. The instrument utilizes a novel polarimeter design based on a quarter-wave plate and a polarization grating (PG), which provides full linear polarization measurements (Stokes I, Q, and U) in one exposure. The PG also has high transmission across the J and H bands. The instrument is situated at the prime focus of an equatorially mounted telescope. As a result, the system only has one reflection in the light path providing minimal telescope induced polarization. A data reduction pipeline has been developed for WIRC+Pol to produce linear polarization measurements from observations. WIRC+Pol has been on-sky since 2017 February. Results from the first year commissioning data show that the instrument has a high dispersion efficiency as expected from the polarization grating. We demonstrate the polarimetric stability of the instrument with rms variation at 0.2% level over 30 minutes for a bright standard star (J = 8.7). While the spectral extraction is photon noise limited, polarization calibration between sources remain limited by systematics, likely related to gravity dependent pointing effects. We discuss instrumental systematics we have uncovered in the data, their potential causes, along with calibrations that are necessary to eliminate them. We describe a modulator upgrade that will eliminate the slowly varying systematics and provide polarimetric accuracy better than 0.1%

Ethnic Variation in Inflammatory Profile in Tuberculosis

PMCID: PMC3701709This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment

Calcidiol, the major circulating metabolite of vitamin D, supports induction of pleiotropic antimicrobial responses in vitro. Vitamin D supplementation elevates circulating calcidiol concentrations, and thus has a potential role in the prevention and treatment of infection. The immunomodulatory effects of administering vitamin D to humans with an infectious disease have not previously been reported. To characterize these effects, we conducted a detailed longitudinal study of circulating and antigen-stimulated immune responses in ninety-five patients receiving antimicrobial therapy for pulmonary tuberculosis who were randomized to receive adjunctive high-dose vitamin D or placebo in a clinical trial, and who fulfilled criteria for per-protocol analysis. Vitamin D supplementation accelerated sputum smear conversion and enhanced treatment-induced resolution of lymphopaenia, monocytosis, hypercytokinaemia, and hyperchemokinaemia. Administration of vitamin D also suppressed antigen-stimulated proinflammatory cytokine responses, but attenuated the suppressive effect of antimicrobial therapy on antigen-stimulated secretion of IL-4, CC chemokine ligand 5, and IFN-α. We demonstrate a previously unappreciated role for vitamin D supplementation in accelerating resolution of inflammatory responses during tuberculosis treatment. Our findings suggest a potential role for adjunctive vitamin D supplementation in the treatment of pulmonary infections to accelerate resolution of inflammatory responses associated with increased risk of mortality

Cohort profile for the STratifying Resilience and Depression Longitudinally (STRADL) study:A depression-focused investigation of Generation Scotland, using detailed clinical, cognitive, and neuroimaging assessments

Grant information: STRADL is supported by the Wellcome Trust through a Strategic Award (104036/Z/14/Z). GS:SFHS received core support from the CSO of the Scottish Government Health Directorates (CZD/16/6) and the Scottish Funding Council (HR03006). ADM is supported by Innovate UK, the European Commission, the Scottish Funding Council via the Scottish Imaging Network SINAPSE, and the CSO. HCW is supported by a JMAS SIM Fellowship from the Royal College of Physicians of Edinburgh, by an ESAT College Fellowship from the University of Edinburgh, and has received previous funding from the Sackler Trust. LR has previously received financial support from Pfizer (formerly Wyeth) in relation to imaging studies of people with schizophrenia and bipolar disorder. JDH is supported by the MRC. DJM is an NRS Clinician, funded by the CSO. RMR is supported by the British Heart Foundation. ISP-V and MRM are supported by the NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health; and MRM is also supported by the MRC MC_UU_12013/6). JMW is supported by MRC UK Dementia Research Institute and MRC Centre and project grants, EPSRC, Fondation Leducq, Stroke Association, British Heart Foundation, Alzheimer Society, and the European Union H2020 PHC-03-15 SVDs@Target grant agreement (666881). DJP is supported by Wellcome Trust Longitudinal Population Study funding (216767/Z/19/Z) the Eva Lester bequest to the University of Edinburgh. AMM is additionally supported by the MRC (MC_PC_17209, MC_PC_MR/R01910X/1, MR/S035818/1), The Wellcome Trust (216767/Z/19/Z ), The Sackler Trust, and has previously received research funding from Pfizer, Eli Lilly, and Janssen. Both AMM and IJD are members of The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (MR/K026992/1); funding from the BBSRC and MRC is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscriptPeer reviewedPublisher PD

WIRC+Pol: A Low-resolution Near-infrared Spectropolarimeter

WIRC+Pol is a newly commissioned low-resolution (R ~ 100), near-infrared (J and H bands) spectropolarimetry mode of the Wide-field InfraRed Camera (WIRC) on the 200 inch Hale Telescope at Palomar Observatory. The instrument utilizes a novel polarimeter design based on a quarter-wave plate and a polarization grating (PG), which provides full linear polarization measurements (Stokes I, Q, and U) in one exposure. The PG also has high transmission across the J and H bands. The instrument is situated at the prime focus of an equatorially mounted telescope. As a result, the system only has one reflection in the light path providing minimal telescope induced polarization. A data reduction pipeline has been developed for WIRC+Pol to produce linear polarization measurements from observations. WIRC+Pol has been on-sky since 2017 February. Results from the first year commissioning data show that the instrument has a high dispersion efficiency as expected from the polarization grating. We demonstrate the polarimetric stability of the instrument with rms variation at 0.2% level over 30 minutes for a bright standard star (J = 8.7). While the spectral extraction is photon noise limited, polarization calibration between sources remain limited by systematics, likely related to gravity dependent pointing effects. We discuss instrumental systematics we have uncovered in the data, their potential causes, along with calibrations that are necessary to eliminate them. We describe a modulator upgrade that will eliminate the slowly varying systematics and provide polarimetric accuracy better than 0.1%